ResMed Inc. is set to release its quarterly earnings on July 31, 2025, with analysts divided on expectations, amidst a broader market context of significant financial disclosures from other major players.

ResMed Inc. is expected to report strong quarterly earnings on July 31, 2025, with analysts projecting an 8.77% increase in revenue and a notable increase in earnings per share.

ResMed Inc. is a strong performer in the health care sector, with a solid track record of growth and innovation, making it a compelling investment opportunity.

ResMed Inc. reports an 8% revenue increase in Q3 2025, driven by strong demand for sleep health products, solidifying its position as a leader in the health care equipment and supplies sector.

ResMed Inc.’s shares surged 5.39% to €199.50 after the company reported an 8% increase in Q3 revenue, driven by strong demand for its sleep health products and strategic initiatives aimed at enhancing shareholder value.